Drug discontinuation: Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered (ADVAIR HFA)
FDA lists 3 presentations as To Be Discontinued. Companies: GlaxoSmithKline.
- Published by source
- 2026-07-27
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- GlaxoSmithKline
- Products
- Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered ADVAIR HFA
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-07-27
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #880 | new | 2026-10-22 | 9441ed9cd15c…909f51 | 0aeeb2a4e572…a2ce0b |
Chain head: #1094 edf3be25ec2e…478842